Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Four Seasons Ventures LLC (FSV) is a venture capital firm established in 2004 and located in Washington, DC. The firm focuses on transitioning next-generation technologies from United States Government (USG) research agency laboratories into the private sector for commercialization. FSV's General Partners possess extensive experience across various fields, including material sciences, nuclear physics, missile defense, pharmacology, toxicology, military strategy, and aerospace. This diverse expertise stems from their previous senior roles in both government and private sectors.
As of now, FSV operates with a unique investment model that emphasizes technologies already supported by ongoing federal funding. This approach significantly reduces development risk and facilitates smoother transitions to commercialization. The firm has maintained a discreet operational profile, with no public disclosures regarding fund size or portfolio count. Its strategic location in Washington, DC, provides access to key government agencies such as the Department of Defense (DOD), National Institutes of Health (NIH), and Defense Advanced Research Projects Agency (DARPA), enhancing its ability to identify and invest in promising technologies.
Four Seasons Ventures invests in revolutionary next-generation technologies that have clear applications in both government and private sectors. The firm specifically targets technologies that address large unmet demands and are supported by ongoing U.S. Government funding. FSV avoids sectors that require FDA approval, such as software, telecommunications, and biotech, focusing instead on engineering, defense, national security, and adjacent areas that align with its investment thesis.
FSV seeks opportunities with strong scientific foundations, cooperative founders, distinctive technologies, and solid intellectual property positions. The firm’s investment strategy is designed to back technologies that are already validated by federal funding, thereby reducing early-stage capital risk for portfolio companies. This unique positioning allows FSV to bridge the gap between government research and private sector commercialization effectively.
General Wesley K. Clark - General Clark has a distinguished military career and extensive experience in national security and defense. He has held senior leadership roles in various capacities, contributing to his expertise in military strategy and operations.
Colonel Jim Ervin - Colonel Ervin brings a wealth of knowledge in military operations and strategy, having served in various leadership positions within the armed forces. His background enhances FSV's focus on defense-related technologies.
Dr. Michael Goldblatt - Dr. Goldblatt has a strong background in pharmacology and toxicology, providing valuable insights into the commercialization of technologies in these fields. His expertise supports FSV's investment in scientifically grounded technologies.
General Les Lyles - General Lyles has extensive experience in aerospace and defense, having held senior roles in both government and private sectors. His leadership experience contributes to FSV's strategic direction.
Mr. Joel W. McCleary - Mr. McCleary has a background in investment research and venture capital, bringing analytical skills that support FSV's investment decision-making process.
Ms. Véronique Bardach - Ms. Bardach has experience in operations and executive management, providing operational support and strategic guidance to portfolio companies.
To pitch to Four Seasons Ventures, startups should send an email to info@fsvcapital.com. A well-structured pitch deck is essential, detailing the technology, its applications, market potential, and funding requirements. Founders should highlight any existing federal funding support, as this aligns with FSV's investment strategy.
While specific response time expectations are not disclosed, startups should anticipate a thorough review process given the firm's focus on technologies with strong scientific foundations. Warm introductions may enhance the chances of securing a meeting, but are not strictly necessary.
What are Four Seasons Ventures' investment criteria?
FSV focuses on next-generation technologies with applications in both government and private sectors. They prioritize technologies that are supported by ongoing U.S. Government funding and have strong scientific foundations.
How can startups apply or pitch to Four Seasons Ventures?
Startups can reach out via email at info@fsvcapital.com to initiate discussions about potential investment opportunities. A detailed pitch deck outlining the technology, market potential, and funding needs is recommended.
What makes Four Seasons Ventures different from other VC firms?
FSV specializes in transitioning government-backed technologies to the private sector, a rare model in the venture capital landscape. Their focus on technologies with existing federal funding reduces development risk significantly.
What is the geographic scope of Four Seasons Ventures?
FSV primarily invests in North America, leveraging its Washington, DC location to access government research and funding opportunities.
What is the typical check size for investments?
While specific check sizes are not disclosed, FSV targets technologies at the point of development readiness and commercial opportunity, suggesting a focus on substantial investments that align with their risk-adjusted return model.
What kind of post-investment involvement does FSV have?
FSV's General Partners, with their extensive backgrounds, likely provide strategic guidance and support to portfolio companies, although specific details on board involvement or operational support are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.